Cero Therapeutics Holdings (NASDAQ: CERO) reported Q2 2024 earnings per share (EPS) of -$0.15, up 34.78% year over year. Total Cero Therapeutics Holdings earnings for the quarter were -$2.45 million. In the same quarter last year, Cero Therapeutics Holdings's earnings per share (EPS) was -$0.23.
As of Q3 2024, Cero Therapeutics Holdings's earnings has grown year over year. Cero Therapeutics Holdings's earnings in the past year totalled N/A.
What was CERO's revenue last quarter?
Cero Therapeutics Holdings (NASDAQ: CERO) reported Q2 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Cero Therapeutics Holdings's revenue was $0.00.
What was CERO's revenue growth in the past year?
As of Q3 2024, Cero Therapeutics Holdings's revenue has grown null year over year. Cero Therapeutics Holdings's revenue in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.